Medical Genetics seminars
December 2022
Microglial efferocytosis: Diving into the Alzheimer's Disease gene pool
Carmen Romero-Molina, Francesca Garretti· Icahn School of Medicine at Mount Sinai
Recorded
Genome-wide association studies and functional genomics studies have linked specific cell types, genes, and pathways to Alzheimer’s disease (AD) risk. In particular, AD risk alleles primarily affect the abundance or structure, and thus the activity, of genes expressed in macrophages, strongly implicating microglia (the brain-resident macrophages) in the etiology of AD. These genes converge on pathways (endocytosis/phagocytosis, cholesterol metabolism, and immune response) with critical roles in core macrophage functions such as efferocytosis. Here, we review these pathways, highlighting relevant genes identified in the latest AD genetics and genomics studies, and describe how they may contribute to AD pathogenesis. Investigating the functional impact of AD-associated variants and genes in microglia is essential for elucidating disease risk mechanisms and developing effective therapeutic approaches." https://doi.org/10.1016/j.neuron.2022.10.015
May 2022
Mitochondrial leukodystrophies
Anna Ardissone· Institute of Neurology Carlo Besta, Milan, Italy
Recorded
February 2022
Learning by example: HD-JUNIOR a national registry for patients with juvenile onset Huntington's Disease
Hannah Bakels· Leiden University Medical Center, the Netherlands
Recorded
January 2022
ASO RNA splice modulating therapies for genetic brain disorders
Willeke van Roon-Mom· University of Leiden, the Netherlands
Recorded
October 2021
X-linked adrenoleukodystrophies - Update
Caroline Sevin· Reference Center for Leukodystrophies, Hospital Bicêtre and Institute for Brain and Spine, Paris, France
Recorded
End of results.